Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
about
Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal diseaseThe incidence rate and economic burden of community-acquired pneumonia in a working-age populationThe Impact of Patient Profiles and Procedures on Hospitalization Costs through Length of Stay in Community-Acquired Pneumonia Patients Based on a Japanese Administrative DatabaseValidation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population.Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational studyThe changing microbiologic epidemiology of community-acquired pneumonia.Costs associated with community acquired pneumonia in France.Burden of community-acquired pneumonia in adults over 18 y of age.National Trends in Admission for Aspiration Pneumonia in the United States, 2002-2012.Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.Relationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer.Treatment of Community-Acquired Pneumonia: A Case Report and Current Treatment Dilemmas.Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary diseaseEconomic burden of community-acquired pneumonia among elderly patients: a Japanese perspective.Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly.
P2860
Q26798305-5FEB3070-58EE-4155-ADE2-FE995DDDA5DCQ33652914-8841EBB1-2711-4EDA-8FF7-EEE00E1E4945Q35553430-F3857A51-5D49-41FC-9E82-919CAC5392D1Q35892486-74F16E64-5975-4950-A219-952D46CFC94AQ36106238-0118A34E-9516-4F2F-95CE-E53925DD33F6Q36121879-3517CFF2-67B8-4116-B973-75A53E4A198EQ38160635-DB3EC7F8-6B1D-418E-8E58-9CB350844924Q38762048-AE29B4FE-F0FA-4789-BAEA-88F34B62D47BQ38915123-465F54E5-342F-4D86-B0C0-A090CEB72C66Q38921052-EC0031EE-ECF6-4868-A95E-9F8FC6F2EF0BQ40744243-0EECB4E5-12B2-469A-8228-7E460EC06601Q40834657-C7BF3888-8896-4175-9C0C-58B444EF9B74Q40982975-72B61219-3AD5-4FFE-88E8-9C8461B8F1F8Q42701714-ADA51490-9F48-4550-B084-4B54DC9FBD6AQ47333699-7A4341BC-21E8-47A3-B977-6B948BDA91B3Q48222344-2D709054-50FF-442B-9851-EA66F1888B32Q55267236-4462B420-68EC-4E4C-99FA-15B7F899FA17
P2860
Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Community-acquired pneumonia e ...... ured US adults aged ≥50 years.
@en
type
label
Community-acquired pneumonia e ...... ured US adults aged ≥50 years.
@en
prefLabel
Community-acquired pneumonia e ...... ured US adults aged ≥50 years.
@en
P2093
P2860
P1476
Community-acquired pneumonia e ...... ured US adults aged ≥50 years.
@en
P2093
Brett Pinsky
Gabriel Gomez Rey
Reiko Sato
Stephanie Nelson
P2860
P2888
P304
P356
10.1007/S40258-013-0026-0
P577
2013-06-01T00:00:00Z